Dr. Martens Plc (3U2) Financial Statements
Dr. Martens Plc Financial Overview
Dr. Martens Plc's market cap is currently $750.77M. The company's EPS TTM is $0.02; its P/E ratio is 26.34; and it has a dividend yield of 3.84%. Dr. Martens Plc is estimated to report earnings on November 19, 2026, and the estimated EPS forecast is $-0.00. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 764.90M | $ 787.60M | $ 877.10M | $ 1.00B | $ 908.30M |
| Gross Profit | $ 506.00M | $ 511.70M | $ 575.20M | $ 618.10M | $ 578.80M |
| Operating Income | $ 73.40M | $ 56.10M | $ 126.40M | $ 180.80M | $ 228.10M |
| EBITDA | $ 142.10M | $ 110.50M | $ 196.30M | $ 235.00M | $ 265.10M |
| Net Income | $ 23.80M | $ 4.50M | $ 69.20M | $ 128.90M | $ 181.20M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 180.30M | $ 155.90M | $ 111.10M | $ 157.50M | $ 228.00M |
| Total Assets | $ 877.30M | $ 889.80M | $ 952.40M | $ 992.60M | $ 859.10M |
| Total Debt | $ 393.50M | $ 404.10M | $ 477.00M | $ 451.80M | $ 393.80M |
| Net Debt | $ 213.20M | $ 248.20M | $ 365.90M | $ 294.30M | $ 165.80M |
| Total Liabilities | $ 515.80M | $ 523.40M | $ 584.20M | $ 588.40M | $ 530.90M |
| Stockholders' Equity | $ 361.50M | $ 366.40M | $ 368.20M | $ 404.20M | $ 328.20M |
| Cash Flow | |||||
| Free Cash Flow | $ 116.30M | $ 177.60M | $ 139.50M | $ 25.90M | $ 159.40M |
| Operating Cash Flow | $ 125.50M | $ 196.30M | $ 167.90M | $ 77.30M | $ 184.40M |
| Investing Cash Flow | $ -11.90M | $ -15.30M | $ -25.50M | $ -50.60M | $ -25.00M |
| Financing Cash Flow | $ -86.90M | $ -134.20M | $ -185.90M | $ -99.50M | $ -47.00M |
Currency in GBP